文献速递冠心病心力衰竭与心肌病

前壁ST段抬高型心肌梗死再灌注前左心室卸载的初步研究

Unloading the Left Ventricle Before Reperfusion in Patients With Anterior ST-Segment-Elevation Myocardial Infarction.
PubMed 文献 · Circulation · 2019-01-01

DTU-STEMI试验为多中心前瞻性随机探索性安全可行性研究,纳入50例无心源性休克的前壁STEMI患者,比较Impella CP左心室卸载后立即再灌注与卸载30分钟后延迟再灌注。30天主要不良心脑血管事件率两组无统计学差异,延迟再灌注未影响30天梗死面积,未发现阻碍开展更大规模关键研究的安全性信号。

要点

  • 前壁STEMI无休克患者中,Impella CP卸载后延迟30分钟再灌注可行。
  • 30天主要不良心脑血管事件率立即再灌注组8%对延迟组12%,无统计学差异。
  • 30天平均梗死面积占左心室质量百分比两组无统计学差异。

核心结论

  • 前壁STEMI患者使用Impella CP行左心室卸载并在再灌注前延迟30分钟是可行的,且未发现阻碍开展更大规模关键研究的安全性信号。
  • 需要开展有足够把握度的关键性试验,比较再灌注前左心室卸载与当前标准治疗。

研究设计与样本

  • 多中心、前瞻性、随机探索性安全性与可行性试验,纳入50例前壁STEMI患者。
  • 患者随机分入左心室卸载后立即再灌注组(U-IR,n=25)或卸载30分钟后延迟再灌注组(U-DR,n=25)。
  • 主要安全性结局为30天主要不良心脑血管事件复合终点,疗效参数包括心脏磁共振评估的梗死面积。

主要发现

  • U-IR组与U-DR组平均门-球时间分别为72分钟与97分钟。
  • 30天主要不良心脑血管事件率U-IR组8%对U-DR组12%,差异无统计学意义(P=0.99)。
  • 30天平均梗死面积占左心室质量百分比U-IR组15±12%对U-DR组13±11%,差异无统计学意义(P=0.53)。

临床怎么用

  • 在前壁STEMI无心源性休克患者中,可考虑使用Impella CP行左心室卸载并延迟再灌注,但当前证据仅支持其安全可行性,尚不能替代标准治疗。
  • 该策略需在更大规模关键性试验验证后方可常规推广。

局限性

  • 本研究为探索性试点试验,样本量仅50例,不足以评估临床结局的统计学差异。
  • 研究未设标准治疗对照组,仅比较两种卸载策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In ST-segment-elevation myocardial infarction (STEMI), infarct size correlates directly with heart failure and mortality. Preclinical testing has shown that, in comparison with reperfusion alone, mechanically unloading the left ventricle (LV) before reperfusion reduces infarct size and that 30 minutes of unloading activates a cardioprotective program that limits reperfusion injury. The DTU-STEMI pilot trial (Door-To-Unload in STEMI Pilot Trial) represents the first exploratory study testing whether LV unloading and delayed reperfusion in patients with STEMI without cardiogenic shock is safe and feasible. METHODS: In a multicenter, prospective, randomized exploratory safety and feasibility trial, we assigned 50 patients with anterior STEMI to LV unloading by using the Impella CP followed by immediate reperfusion (U-IR) versus delayed reperfusion after 30 minutes of unloading (U-DR). The primary safety outcome was a composite of major adverse cardiovascular and cerebrovascular events at 30 days. Efficacy parameters included the assessment of infarct size by using cardiac magnetic resonance imaging. RESULTS: All patients completed the U-IR (n=25) or U-DR (n=25) protocols with respective mean door-to-balloon times of 72 versus 97 minutes. Major adverse cardiovascular and cerebrovascular event rates were not statistically different between the U-IR versus U-DR groups (8% versus 12%, respectively, P=0.99). In comparison with the U-IR group, delaying reperfusion in the U-DR group did not affect 30-day mean infarct size measured as a percentage of LV mass (15±12% versus 13±11%, U-IR versus U-DR, P=0.53). CONCLUSIONS: We report that LV unloading using the Impella CP device with a 30-minute delay before reperfusion is feasible within a relatively short time period in anterior STEMI. The DTU-STEMI pilot trial did not identify prohibitive safety signals that would preclude proceeding to a larger pivotal study of LV unloading before reperfusion. An appropriately powered pivotal trial comparing LV unloading before reperfusion to the current standard of care is required. CLINICAL TRIAL REGISTRATION: URL: https://www.clinicaltrials.gov . Unique identifier: NCT03000270.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Kapur NK, Alkhouli MA, DeMartini TJ, et al. Unloading the Left Ventricle Before Reperfusion in Patients With Anterior ST-Segment-Elevation Myocardial Infarction. Circulation. 2019. PMID: 30586728. doi:10.1161/CIRCULATIONAHA.118.038269

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。